{"id":"NCT01014689","sponsor":"Galderma R&D","briefTitle":"Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris","officialTitle":"Efficacy and Safety Comparison of Epiduo Gel Associated With Lymecycline 300 mg Capsules Versus Epiduo Vehicle Gel Associated With Lymecycline 300 mg Capsules in the Treatment of Moderate to Severe Acne Vulgaris","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-08","primaryCompletion":"2010-04","completion":"2010-05","firstPosted":"2009-11-17","resultsPosted":"2012-04-05","lastUpdate":"2021-02-18"},"enrollment":378,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Acne Vulgaris"],"interventions":[{"type":"DRUG","name":"Adapalene/ BPO gel with Lymecycline capsules","otherNames":["Adapalene/BPO with Lymecycline"]},{"type":"DRUG","name":"Adapalene/ BPO vehicle gel with Lymecycline capsules","otherNames":["Adapalene/BPO vehicle with Lymecycline"]}],"arms":[{"label":"Adapalene 0.1% / BPO 2.5% gel","type":"ACTIVE_COMPARATOR"},{"label":"Adapalene 0.1% / BPO 2.5% Vehicle Gel","type":"PLACEBO_COMPARATOR"}],"summary":"Randomized, controlled, multi-center, double-blind, parallel-group comparison study in Subjects with moderate to severe acne vulgaris on the face.\n\nThe purpose of this study is to demonstrate the efficacy of Adapalene 0.1% / Benzoyl Peroxide (BPO) 2.5% Gel associated with Lymecycline 300mg Capsules compared to Adapalene 0.1% /Benzoyl Peroxide 2.5% Vehicle Gel associated with Lymecycline 300mg Capsules, in the treatment of moderate to severe acne vulgaris.\n\nThe safety of the two treatment regimens will also be evaluated.","primaryOutcome":{"measure":"Percent Change From Baseline in Total Lesion Count","timeFrame":"Baseline and Week 12","effectByArm":[{"arm":"Adapalene 0.1% / BPO 2.5% Gel + Lymecycline","deltaMin":-74.1,"sd":null},{"arm":"Adapalene 0.1% / BPO 2.5% Vehicle Gel + Lymecycline","deltaMin":-56.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":28,"countries":["Australia","Belgium","Brazil","France","Germany","Italy","Mexico","Poland","Sweden"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":191},"commonTop":["HEADACHE","NASOPHARYNGITIS"]}}